CEO Ram Rao Discusses Juvene, the Rise of Presbyopia, and How LensGen Raised $21 million

05/10/17 • 11 min

OIS Podcast | Ophthalmology's leading Podcast

LensGen CEO Ram Rao discusses his company’s $21 million Series A and the increased interest in presbyopia.

LensGen CEO Ram Rao discusses his company’s $21 million Series A and the increased interest in presbyopia.

Previous Episode

In an Insightful Wrap-up, OIS Co-chairs Share the Top Takeaways from another Successful OIS@ASCRS

Emmett Cunningham, MD, Gil Kliman, MD, and Bill Link, PhD, co-chairs of OIS, talk about device funding, myopia, and the Masters of the Industry following a successful OIS@ASCRS.

Next Episode

Alice Epitropoulos, MD, on How Xiidra, TrueTear, and Other Treatments Impact Practices, Patients

Now that Shire’s Xiidra claims a 20% market share, find out how it’s impacting the practice. Alice Epitropoulos, MD, of Ophthalmic Surgeons & Consultants of Ohio, sat down with OIS-TV to explain how Shire, TrueTear, and other advances are impacting her Dry Eye patients.